연혁
2017
Aug
Listing in the Canada Stock Exchange (CSE)
2016
Oct
Contracted joint venture for FMD Vaccine production with Pharos Vaccine, Korea
Oct
Bio-similar and a FMD Vaccine joint factory project with ORNA, Turkey
Oct
Started Production of hair production containing 5 kinds of growth factors
Jul
Final discussing a Bio-similar joint factory project with Royan Group, Iran
Aug
Established Biopharma-Switzerland in Zurich, Switzerland (main shareholder)
2015
Sep
Completed capital increase with consideration (issued total 3,158,887 shares)
Jan
Agreed with Biocurepharm-C company(Turkey) for joint development of Ranibizumab
2012
Jan
Established Biocurepharm-MG in Singapore with Macauley Gehler
Aug
Attracted FDI USD500Mil from Macauley Gehler, Singapore
2011
Mar
Completed joint development of a detection kit of breast cancer (clinical test started)
2007
Dec
Achieved export of USD 4.5 million
2006
Nov
Awarded the national export tower of USD 1 million
2005
Aug
Company founded (Paid-in capital of USD 50,000)